1. Home
  2. |Insights
  3. |ACI 24th Annual Conference on Drug & Medical Device Litigation

ACI 24th Annual Conference on Drug & Medical Device Litigation

Event | 12.09.19 - 12.10.19, 3:30 AM EST - 12:00 PM EST

Address

New York Marriott Marquis
1535 Broadway, New York, NY, 10036

ACI’s Drug and Medical Device Litigation conference is the only event which brings together an exceptional in-house presence on the faculty, the top defense firms representing pharmaceutical and medical device companies, experienced jurists from around the country, the FDA, and the DOJ. Designed for both networking and masters-level strategy sharing, this is the leading forum at which to learn winning life sciences products liability litigation strategies.


Partner Andrew Kaplan will participate in a panel titled, "Combatting Extreme Jury Verdicts: Navigating Extraneous Factors That are Influencing Juror Findings" on Tuesday, December 10th at 3:30 pm.

For more information, please visit these areas: Mass Tort, Product, and Consumer Litigation, Medical Devices

Insights

Event | 05.14.25

"The Tide is High: New Guidance on Sea-Level Rise," The Bar Association of San Francisco

Jon Welner will be interviewing Larry Goldzband, the Executive Director of the San Francisco Bay Conservation and Development Commission (BCDC), on the Commission’s new plan to prepare the SF Bay Area for sea-level rise. BCDC is the agency responsible for permitting all development on the shoreline of San Francisco Bay. On December 5, 2024, the BCDC adopted the Regional Shoreline Adaptation Plan (RSAP). The RSAP is a region-wide plan for the San Francisco Bay shoreline that guides the creation of coordinated, locally planned sea level rise adaptation actions that work together to achieve a regional One Bay Vision. This includes BCDC’s guidelines for how local governments must meet the requirements of SB 272, a new State mandate that requires all local governments along the shoreline to prepare a Subregional Shoreline Adaptation Plan by 2034.